BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du WJ, Zhen JH, Zeng ZQ, Zheng ZM, Xu Y, Qin LY, Chen SJ. Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagn Pathol. 2013;8:40. [PMID: 23448394 DOI: 10.1186/1746-1596-8-40] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Metanat M, Alijani E, Ansari-moghaddam A, Bahrehmand F, Khalili M, Arbabi N, Khosravi S, Sanei Moghadam E, Alavi-naini R. The Relationship Between Serum IL-17 Level and Viral Load in Chronic Hepatitis B. Arch Clin Infect Dis 2019;14. [DOI: 10.5812/archcid.68172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Li ZQ, Hu CL, Yu P, Gu XY, Zhang JJ, Li H, Zhang HY, Lv J, Liu YM, Zeng QL, Yan JY, Yu ZJ, Zhang Y. The development of hepatocarcinoma after long-term antivirus treatment of Chinese patients with chronic hepatitis B virus infection: Incidence, long-term outcomes and predictive factors. Clin Res Hepatol Gastroenterol. 2017;41:311-318. [PMID: 28237828 DOI: 10.1016/j.clinre.2016.11.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
3 Lasagni C, Bigi L, Conti A, Pellacani G. Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies. J Dermatolog Treat 2018;29:5-8. [PMID: 30403898 DOI: 10.1080/09546634.2018.1543843] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
4 Vatsalya V, Li F, Frimodig J, Gala KS, Srivastava S, Kong M, Ramchandani VA, Feng W, Zhang X, McClain CJ. Repurposing Treatment of Wernicke-Korsakoff Syndrome for Th-17 Cell Immune Storm Syndrome and Neurological Symptoms in COVID-19: Thiamine Efficacy and Safety, In-Vitro Evidence and Pharmacokinetic Profile. Front Pharmacol 2020;11:598128. [PMID: 33737877 DOI: 10.3389/fphar.2020.598128] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cohen JM, Kridin K, Perez-Chada LM, Merola JF, Cohen AD. Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study. Int J Dermatol 2021. [PMID: 33998670 DOI: 10.1111/ijd.15578] [Reference Citation Analysis]
6 He WM, Su Y. Progress in research of IL-10 and IL-17 in chronic hepatitis B, hepatitis B virus-related liver cirrhosis and cirrhosis with abdominal infection. Shijie Huaren Xiaohua Zazhi 2014; 22(3): 333-339 [DOI: 10.11569/wcjd.v22.i3.333] [Reference Citation Analysis]
7 He Y, Du Y, Wei S, Shi J, Mei Z, Qian L, Chen Z, Jie Z. IL-17A and IL-17F single nucleotide polymorphisms associated with lung cancer in Chinese population: Associations of IL-17 SNPs and lung cancer. The Clinical Respiratory Journal 2017;11:230-42. [DOI: 10.1111/crj.12330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
8 Blessing WA, Williamson AK, Kirsch JR, Grinstaff MW. The Prognosis of Arthrofibroses: Prevalence, Clinical Shortcomings, and Future Prospects. Trends Pharmacol Sci 2021;42:398-415. [PMID: 33795150 DOI: 10.1016/j.tips.2021.02.007] [Reference Citation Analysis]
9 Wang J, Liu Y, Xie L, Li S, Qin X. Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study. Clin Res Hepatol Gastroenterol 2016;40:288-96. [PMID: 26546176 DOI: 10.1016/j.clinre.2015.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
10 Ruiz de Morales JMG, Puig L, Daudén E, Cañete JD, Pablos JL, Martín AO, Juanatey CG, Adán A, Montalbán X, Borruel N, Ortí G, Holgado-martín E, García-vidal C, Vizcaya-morales C, Martín-vázquez V, González-gay MÁ. Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies. Autoimmunity Reviews 2020;19:102429. [DOI: 10.1016/j.autrev.2019.102429] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 28.5] [Reference Citation Analysis]
11 Wang P, Gao XS, Zhang YN, Duan XF. Progress in research of non-cirrhotic chronic viral hepatitis with osteoporosis. Shijie Huaren Xiaohua Zazhi 2022; 30(11): 491-497 [DOI: 10.11569/wcjd.v30.i11.491] [Reference Citation Analysis]
12 Nati M, Haddad D, Birkenfeld AL, Koch CA, Chavakis T, Chatzigeorgiou A. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Rev Endocr Metab Disord. 2016;17:29-39. [PMID: 26847547 DOI: 10.1007/s11154-016-9339-2] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 12.8] [Reference Citation Analysis]
13 Molina MF, Abdelnabi MN, Fabre T, Shoukry NH. Type 3 cytokines in liver fibrosis and liver cancer. Cytokine 2019;124:154497. [DOI: 10.1016/j.cyto.2018.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
14 Arsenijevic A, Milovanovic M, Milovanovic J, Stojanovic B, Zdravkovic N, Leung PS, Liu FT, Gershwin ME, Lukic ML. Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. Sci Rep. 2016;6:23348. [PMID: 26996208 DOI: 10.1038/srep23348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
15 Cheng LS, Liu Y, Jiang W. Restoring homeostasis of CD4+ T cells in hepatitis-B-virus-related liver fibrosis. World J Gastroenterol 2015; 21(38): 10721-10731 [PMID: 26478664 DOI: 10.3748/wjg.v21.i38.10721] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
16 Liang KH, Lai MW, Lin YH, Chu YD, Lin CL, Lin WR, Huang YH, Wang TH, Chien RN, Hu TH, Yeh CT. Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients. BMC Gastroenterol 2021;21:177. [PMID: 33865328 DOI: 10.1186/s12876-021-01761-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lee TL, Tsai TF. Non-immune functions of inflammatory cytokines targeted by anti-psoriatic biologics: a review. Inflamm Res 2022. [PMID: 34981130 DOI: 10.1007/s00011-021-01528-0] [Reference Citation Analysis]
18 Xue ZM, Yao DM. Th17 cells and liver diseases. Shijie Huaren Xiaohua Zazhi 2013; 21(13): 1185-1190 [DOI: 10.11569/wcjd.v21.i13.1185] [Reference Citation Analysis]
19 An SY, Petrescu AD, DeMorrow S. Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis. Front Pharmacol 2021;12:645703. [PMID: 33841164 DOI: 10.3389/fphar.2021.645703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Qinghai Z, Yanying W, Yunfang C, Xukui Z, Xiaoqiao Z. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene. 2014;537:328-332. [PMID: 24315816 DOI: 10.1016/j.gene.2013.11.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
21 Chen YS, Huang TH, Liu CL, Chen HS, Lee MH, Chen HW, Shen CR. Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model. Hum Gene Ther 2019;30:273-85. [PMID: 30079767 DOI: 10.1089/hum.2018.104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
22 Giles DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, Huppert SS, Iwakura Y, Dong C, Shanmukhappa SK, Divanovic S. Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis. PLoS One. 2016;11:e0149783. [PMID: 26895034 DOI: 10.1371/journal.pone.0149783] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
23 Bao S, Zheng J, Shi G. The role of T helper 17 cells in the pathogenesis of hepatitis B virus-related liver cirrhosis (Review). Mol Med Rep 2017;16:3713-9. [PMID: 28731149 DOI: 10.3892/mmr.2017.7044] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Zhao Y, Wang J, Zhang J, Sun Z, Niu R, Manthari RK, Ommati MM, Wang S, Wang J. Fluoride exposure induces mitochondrial damage and mitophagy via activation of the IL-17A pathway in hepatocytes. Sci Total Environ 2021;804:150184. [PMID: 34517333 DOI: 10.1016/j.scitotenv.2021.150184] [Reference Citation Analysis]
25 Taniki N, Nakamoto N, Chu PS, Ichikawa M, Teratani T, Kanai T. Th17 cells in the liver: balancing autoimmunity and pathogen defense. Semin Immunopathol 2022. [PMID: 35211777 DOI: 10.1007/s00281-022-00917-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Cooksley H, Riva A, Katzarov K, Hadzhiolova-Lebeau T, Pavlova S, Simonova M, Williams R, Chokshi S. Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B. J Interferon Cytokine Res 2018;38:273-82. [PMID: 30016182 DOI: 10.1089/jir.2017.0109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
27 Li H, Ding P, Peng B, Ming YZ. Cross-talk between hepatic stellate cells and T lymphocytes in liver fibrosis. Hepatobiliary Pancreat Dis Int 2021;20:207-14. [PMID: 33972160 DOI: 10.1016/j.hbpd.2021.04.007] [Reference Citation Analysis]
28 Paquissi FC. Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets. Front Immunol 2016;7:490. [PMID: 27891128 DOI: 10.3389/fimmu.2016.00490] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
29 Li X, Liu X, Tian L, Chen Y. Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections. Clin Rev Allergy Immunol. 2016;50:41-54. [PMID: 25480494 DOI: 10.1007/s12016-014-8465-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
30 Ramani K, Biswas PS. Interleukin-17: Friend or foe in organ fibrosis. Cytokine 2019;120:282-8. [PMID: 30772195 DOI: 10.1016/j.cyto.2018.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
31 Ramnath D, Irvine KM, Lukowski SW, Horsfall LU, Loh Z, Clouston AD, Patel PJ, Fagan KJ, Iyer A, Lampe G, Stow JL, Schroder K, Fairlie DP, Powell JE, Powell EE, Sweet MJ. Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight 2018;3:120274. [PMID: 30046009 DOI: 10.1172/jci.insight.120274] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
32 Markowitz GJ, Michelotti GA, Diehl AM, Wang XF. Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma. Sci Bull (Beijing) 2015;60:762-72. [PMID: 26029472 DOI: 10.1007/s11434-015-0772-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
33 von Massow G, Oh S, Lam A, Gustafsson K. Gamma Delta T Cells and Their Involvement in COVID-19 Virus Infections. Front Immunol 2021;12:741218. [PMID: 34777353 DOI: 10.3389/fimmu.2021.741218] [Reference Citation Analysis]
34 Lu YY, Chen QL, Guan Y, Guo ZZ, Zhang H, Zhang W, Hu YY, Su SB. Transcriptional profiling and co-expression network analysis identifies potential biomarkers to differentiate chronic hepatitis B and the caused cirrhosis. Mol Biosyst 2014;10:1117-25. [PMID: 24599568 DOI: 10.1039/c3mb70474b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
35 Rapin N, Johns K, Martin L, Warnecke L, Turner JM, Bollinger TK, Willis CK, Voyles J, Misra V. Activation of innate immune-response genes in little brown bats (Myotis lucifugus) infected with the fungus Pseudogymnoascus destructans. PLoS One 2014;9:e112285. [PMID: 25391018 DOI: 10.1371/journal.pone.0112285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
36 Tavakolpour S, Alavian SM, Sali S. Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection. Hepat Mon 2016;16:e37927. [PMID: 27630728 DOI: 10.5812/hepatmon.37927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Karakas-celik S, Piskin IE, Keni MF, Calık M, Iscan A, Dursun A. May TLR4 Asp299Gly and IL17 His161Arg polymorphism be associated with progression of primary measles infection to subacute sclerosing panencephalitis? Gene 2014;547:186-90. [DOI: 10.1016/j.gene.2014.03.056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
38 Paquissi FC. Immunity and Fibrogenesis: The Role of Th17/IL-17 Axis in HBV and HCV-induced Chronic Hepatitis and Progression to Cirrhosis. Front Immunol. 2017;8:1195. [PMID: 29033929 DOI: 10.3389/fimmu.2017.01195] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
39 Ribeiro CRA, de Almeida NAA, Martinelli KG, Pires MA, Mello CEB, Barros JJ, de Paula VS. Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patients. Virol J 2021;18:15. [PMID: 33435966 DOI: 10.1186/s12985-021-01487-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Macek Jilkova Z, Afzal S, Marche H, Decaens T, Sturm N, Jouvin-Marche E, Huard B, Marche PN. Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils. Liver Int 2016;36:1116-24. [PMID: 26749555 DOI: 10.1111/liv.13060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
41 Su Z, Chen J, Zhang J, An Y, Liao Y, Wu X, Tao C, Wang L, Cai B, Cui D. Circulating IL-1β, IL-17, and IP-10 as Potential Predictors of Hepatitis B Virus Infection Prognosis. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/5202898] [Reference Citation Analysis]
42 Xia M, Liao G, Chen H, Wu Y, Fan R, Zhang X, Peng J. Plasma CXCL13 is a predictive factor for HBsAg loss and clinical relapse after discontinuation of nucleos(t)ide analogue treatment. Clin Immunol 2019;198:31-8. [PMID: 30503407 DOI: 10.1016/j.clim.2018.11.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 Giles DA, Moreno-Fernandez ME, Divanovic S. IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression. Curr Drug Targets 2015;16:1315-23. [PMID: 26028039 DOI: 10.2174/1389450116666150531153627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
44 Borzooy Z, Streinu-Cercel A, Mirshafiey A, Khamseh A, Mahmoudie MK, Navabi SS, Nosrati M, Najafi Z, Hosseini M, Jazayeri SM. IL-17 and IL-22 genetic polymorphisms in HBV vaccine non- and low-responders among healthcare workers. Germs 2016;6:14-20. [PMID: 27019828 DOI: 10.11599/germs.2016.1084] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Rosso C, Caviglia GP, Younes R, Ribaldone DG, Fagoonee S, Pellicano R, Bugianesi E. Molecular mechanisms of hepatic fibrosis in chronic liver diseases. Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02619-1] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Tang S, Liu Z, Zhang Y, He Y, Pan D, Liu Y, Liu Q, Zhang Z, Yuan Y. Rather than Rs1800796 polymorphism, expression of interleukin-6 is associated with disease progression of chronic HBV infection in a Chinese Han population. Dis Markers 2013;35:799-805. [PMID: 24371367 DOI: 10.1155/2013/508023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
47 Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci 2021;22:5497. [PMID: 34071064 DOI: 10.3390/ijms22115497] [Reference Citation Analysis]
48 Pu Y, Zhang S, Zhou R, Huang N, Li H, Wei W, Li L, Huang C, Yang J, Li Z. IL-17A up-regulates expression of endothelial tissue factor in liver cirrhosis via the ROS/p38 signal pathway. Biochemical and Biophysical Research Communications 2016;470:41-7. [DOI: 10.1016/j.bbrc.2015.12.093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
49 Ribeiro CRA, Martinelli KG, de Mello VDM, Baptista BDS, Dias NST, Paiva IA, Lewis-Ximenez LL, Pinto LMO, de Paula VS. Cytokine, Genotype, and Viral Load Profile in the Acute and Chronic Hepatitis B. Viral Immunol 2020;33:620-7. [PMID: 33090087 DOI: 10.1089/vim.2020.0176] [Reference Citation Analysis]
50 Ren W, Wu Z, Ma R, Liu Z, Wang Y, Wu L, Liu S, Wang Z. Polymorphisms in the IL-17 Gene (rs2275913 and rs763780) Are Associated with Hepatitis B Virus Infection in the Han Chinese Population. Genet Test Mol Biomarkers 2017;21:286-91. [PMID: 28277785 DOI: 10.1089/gtmb.2016.0177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
51 Zhou WC, Zhang QB, Qiao L. Pathogenesis of liver cirrhosis. World J Gastroenterol 2014; 20(23): 7312-7324 [PMID: 24966602 DOI: 10.3748/wjg.v20.i23.7312] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 178] [Article Influence: 25.3] [Reference Citation Analysis]
52 Zarogoulidis P, Katsikogianni F, Tsiouda T, Sakkas A, Katsikogiannis N, Zarogoulidis K. Interleukin-8 and interleukin-17 for cancer. Cancer Invest. 2014;32:197-205. [PMID: 24669909 DOI: 10.3109/07357907.2014.898156] [Cited by in Crossref: 58] [Cited by in F6Publishing: 62] [Article Influence: 7.3] [Reference Citation Analysis]
53 Jhun J, Lee S, Kim H, Her YM, Byun JK, Kim EK, Lee SK, Cho ML, Choi JY. HMGB1/RAGE induces IL-17 expression to exaggerate inflammation in peripheral blood cells of hepatitis B patients. J Transl Med 2015;13:310. [PMID: 26391982 DOI: 10.1186/s12967-015-0663-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]